The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Investigation of a 22-gene genomic classifier (GC) for risk stratification and molecular subtyping in an Asian prostate cancer (PCa) cohort.
 
Wei Loong Sherman Yee
No Relationships to Disclose
 
Wai Yee Woo
No Relationships to Disclose
 
Adelene Sim
No Relationships to Disclose
 
Kar Perng Low
No Relationships to Disclose
 
Alice Meng
No Relationships to Disclose
 
Janice Ser Huey Tan
No Relationships to Disclose
 
Jeffrey Tuan
No Relationships to Disclose
 
Terence WK Tan
No Relationships to Disclose
 
Michael Lian Chek Wang
No Relationships to Disclose
 
Kae-Jack Tay
No Relationships to Disclose
 
Christopher Cheng
No Relationships to Disclose
 
Joe Poh Sheng Yeong
No Relationships to Disclose
 
Yang Liu
Employment - Decipher Biosciences; GenomeDx
Stock and Other Ownership Interests - Decipher Biosciences; GenomeDx
 
Lui Shiong Lee
No Relationships to Disclose
 
Ravindran Kanesvaran
Honoraria - Astellas Pharma; Bristol-Myers Squibb; Janssen; MSD Oncology; Novartis
Consulting or Advisory Role - Astellas Pharma; Janssen Oncology; MSD Oncology; Novartis; pfizer
Research Funding - Janssen (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bristol-Myers Squibb; MSD Oncology
 
Michael Chien Sheng Tan
No Relationships to Disclose
 
Elai Davicioni
Employment - Decipher Biosciences; GenomeDx
Leadership - Decipher Biosciences; GenomeDx
Stock and Other Ownership Interests - Decipher Biosciences; GenomeDx
Patents, Royalties, Other Intellectual Property - CANCER DIAGNOSTICS USING BIOMARKERS 20140066323
Travel, Accommodations, Expenses - GenomeDx
 
Li Yan Khor
No Relationships to Disclose
 
Melvin Lee Kiang Chua
Stock and Other Ownership Interests - Varian Medical Systems (I)
Honoraria - Ferring; Janssen Oncology; Varian Medical Systems
Consulting or Advisory Role - Illumina; ImmunoSCAPE; Janssen Oncology; Merck Sharp & Dohme
Speakers' Bureau - AstraZeneca; Bayer
Research Funding - Decipher Biosciences; Ferring; PVmed; Varian Medical Systems
Travel, Accommodations, Expenses - Varian Medical Systems